Due to the potential functional redundancy of three CRTC coactivators in maintaining malignant cell behaviors of LKB1-null lung cancers, an approach of inhibiting all three CRTCs is required to assess the general role of aberrant CRTC activation in promoting tumorigenesis in LKB1-null lung cancer. Here, STK11 is linked to lung cancer.